SlideShare a Scribd company logo
APPROACH TO SHOCK
MODERATOR: DR JAI GAWLI SIR
PRESENTER: DR AYUSHI MUNGAD
DEFINITION
• Shock is clinical condition of organ dysfunction resulting from imbalance between cellular oxygen
supply and demand.
• Life threatening condition.
• Organ dysfunction in early shock is reversible.
• If left untreated, goes in irreversible phase and death occur from multisystem organ dysfunction.
PATHOPHYSIOLOGY OF SHOCK
• Most commonly related to impaired oxygen delivery in the setting of
circulatory failure.
• Can also develop during states of increased oxygen consumption or impaired
oxygen utilization.
• Normal oxygen content in mitochondria is 10 mmHg.
• Critical value in mitochondria is 1-2 mmHg, Below this anerobic
respiration sets in.
• Major oxygen consumers are LIVER, BRAIN, HEART, SKELETAL
MUSCLE, KIDNEY, SKIN.
INSUFFICIENT OXYGEN SUPPLY
ANAEROBIC METABOLISM
INADEQUATE ATP SUPPLY
OSMOTIC, IONIC DISRUPTION
CELLULAR
SWELLING
CELL DEATH
CLASSIFICATION OF SHOCK
• Based on the primary physiologic derangement, shock is classified in
four major types:
1. DISTRIBUTIVE
2. CARDIOGENIC
3. OBSTRUCTIVE
4. HYPOVOLEMIC
PATHOPHYSIOLOGIC CLASSIFICATION OF SHOCK
1. DISTRIBUTIVE SHOCK
• SEPTIC SHOCK
• ANAPHYLACTIC SHOCK
• NEUROGENIC SHOCK
2. CARDIOGENIC SHOCK
• MYOCARDIAL INFARCTION
• VALVULAR INSUFFICIENCY
3. OBSTRUCTIVE SHOCK
• TENSION PNEUMOTHORAX
• INTRATHORACIC TUMOR
• PULMONARY EMBOLISM
4. HYPOVOLEMIC SHOCK
• BURNS
• GI LOSSES
• HEMORRHAGE
• DIABETIC KETOACIDOSIS
• DIABETIC INSIPIDUS
DISTRIBUTIVE SHOCK
• It is the condition of reduced systemic vascular resistance.
• It is unique among the types of shock because there is compensatory
increase in cardiac output.
• Most common cause of distributive shock is sepsis.
• Sepsis: A life threatening organ dysfunction caused by
dysregulated host response to infection.
• Septic shock: Suspected infection (or documented) plus
vasopressor therapy to maintain MAP >65mmHg and serum
lactate >2mmol/L despite adequate fluid resuscitation.
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
SEPSIS
SEPTIC SHOCK
MULTI ORGAN DYSFUNCTION SYNDROME
• ANAPHYLACTIC SHOCK: Predominantly IgE mediated allergic reaction
rapidly develop after exposure to an ALLERGEN.
• It is mediated through histamine release.
• Both arterial and venous vasodilation occur.
NEUROGENIC SHOCK
• In high spinal injuries there is failure of sympathetic outflow.
• Vasodilation
• Pooling of blood
• Decrease venous return
• Decrease cardiac output
• It is sudden in onset.
HYPOVOLEMIC SHOCK
• It is due to reduce cardiac output(and oxygen delivery) via a
reduction in preload.
• Most commonly related to hemorrhage, may be external or internal.
• Non-hemorrhagic processes(GI, Renal, Skin loss) can also lead to
hypovolemic shock.
CLASSIFICATION OF HYPOVOLEMIC SHOCK
I II III IV
% OF VOLUME
LOSS
0-15% 15-30% 30-40% >40%
AMOUNT OF
BLOOD LOSS
400-500mL 500-1500mL 1500-2000mL >2000mL
HR NORMAL NR
SBP NORMAL NORMAL NR
DBP NORMAL NR
RR NORMAL NORMAL
UO NORMAL NORMAL/ ANURIA
I II III IV
MENTAL STATUS NORMAL ANXIOUS AND
THIRSTY
CONFUSED COMA
MANGEMENT ORAL LIQUIDS IV CRYSTALLOIDS IV CRYSTALLOIDS
+ COLLOIDS
MASSIVE BLOOD
TRANFUSION
CARDIOGENIC SHOCK
• It is characterized by reduced oxygen delivery related to
reduction in cardiac output owing to a primary cardiac problem.
• When affects LV, PCWP will be elevated.
• When affects RV, CVP will be elevated.
OBSTRUCTIVE SHOCK
• Reduction in oxygen delivery is related to reduced CO due to an
extracardiac process impairing blood flow.
• Some process can impede venous return and other obstruct cardiac
flow.
• MIXED SHOCK: Patient will present with more than one type of
shock.
• UNDIFFERENTIATED SHOCK
HEMODYNAMIC CHARACTERISTIC OF MAJOR TYPES
OF SHOCK
TYPE OF SHOCK CVP PCWP CARDIAC
OUTPUT
SYSTEMIC
VASCULAR
RESISTANCE
DISTRIBUTIVE DECREASE DECREASE INCREASE DECREASE
CARDIOGENIC INCREASE INCREASE DECREASE INCREASE
OBSTRUCTIVE INCREASE INCREASE OR
DECREASE
DECREASE INCREASE
HYPOVOLEMIC DECREASE DECREASE DECREASE INCREASE
STAGES OF SHOCK
COMPENSATED
SHOCK
(PRESHOCK)
DECOMPENSATED
SHOCK
IRREVERSIBLE
SHOCK
EVALUATION OF PATIENT WITH SHOCK
KEY PRINCIPLES IN THE TREATMENT OF SHOCK
1. RECOGNIZE SHOCK EARLY..
2.ASSESS FOR THE TYPE OF SHOCK PRESENT
3. INITIATE THERAPY SIMULTANEOUS WITH THE EVALUATION INTO ETIOLOGY OF SHOCK.
4. RESTORATION OF OXYGEN DELIVERY IS THE AIM OF THERAPY.
5. IDENTIFY ETIOLOGIES WHICH REQUIRE ADDITIONAL LIFE SAVING INTERVENTIONS
HISTORY TAKING
• In some cases, the type of shock is apparent from history.
• The most easily identified new organ dysfunction is presence of altered
mental status or decrease renal function.
• DISTRIBUTIVE SHOCK FROM SEPSIS- FEVER, FOCAL SITE OF INFECTION.
• DISTRIBUTIVE SHOCK FROM ANAPHYLAXIS- DYSPNEA, NEW FACIAL EDEMA, PRURITIS AFTER
EXPOSURE TO ALLERGEN.
• CARDIOGENIC SHOCK: EXERTIONAL CHEST DISCOMFORT, PALPITATION, CHEST PAIN.
• HYPOVOLEMIC SHOCK: History of trauma or GI bleed.
• OBSTRUCTIVE SHOCK: Tearing chest or back pain with history of HTN or
acute onset chest pain with dyspnea in the setting of immobility.
PHYSICAL EXAMINATION
Physical examination should be conducted with aim of
answering 2 questions:
1.IS SHOCK PRESENT?
2. WHAT TYPE OF SHOCK PRESENT?
• DURING COMPENSATED PHASE: TACHYCARDIA, TACHYPNEA.
• HYPOTENSION MAY ALSO BE PRESENT.
• CNS, KIDNEY AND SKIN ARE THE ORGAN MOST EASILY ASSESED FOR EVIDENCE OF
DYSFUNCTION.
• WARM EXTREMITIES: DISTRIBUTIVE SHOCK.
• COLD EXTREMITIES: HYPOVOLEMIC SHOCK, OBSTRUCTIVE SHOCK, CARDIOGENIC SHOCK.
• URINARY OUTPUT SHOULD BE ASSESED.
• JVP AND PERIPHERAL EDEMA can provide insight into right side cardiac
pressure.
• PULMONARY AUSCULTATION can identify signs of left sided cardiac
dysfunction.
• Examination may demonstrate site of untreated infection, large
ecchymosis.
SCORING SYSTEM
• SHOCK INDEX (SI)= HR/ SYSTOLIC BLOOD PRESSURE
• NORMAL SI IS 0.5-0.7.
• SI >0.9 IS MORE SENSITIVE INDICATOR OF TRANSFUSION REQUIREMENT.
QSOFA
• IT IS A RAPID ASSESSMENT SCALE THAT ASSIGNS A POINT FOR
1. SBP <1OO mmHg.
2. RR >22/MIN.
3. ALTERED MENTAL STATUS.
• qSOFA OF >2 IS ASSOCIATED WITH SIGNIFICANTLY GREATER RISK OF
PROLONGED ICU STAY OR DEATH.
INITIAL LABORATORY EVALUATION OF
UNDIFFERENTIATED SHOCK
1. LACTATE
2. RENAL FUNCTION TEST
3. LIVER FUNCTION TEST
4. CARDIAC ENZYMES
5. COMPLETE BLOOD COUNT
6. PT, INR
7. URINALYSIS
8. ABG
9. ECG
INITIAL TREATMENT OF SHOCK
• VOLUME RESUSCITATION
• VASOPRESSOR AND INOTROPIC SUPPORT
• OXYGEN AND VENTILLATION SUPPORT
• ANTIBIOTIC SUPPORT
VOLUME RESUSCITATION
• Aim is to restore tissue perfusion .
• Patient with suspected septic shock, minimum 30ml/kg is
recommended by surviving sepsis campaign in 1 hr.
• Most commonly volume resuscitation begin with crystalloid.
RINGER LACTATE
INDICATIONS:
1. SEVERE HYPOVOLEMIA
2. DIARRHOEA INDUCED HYPOVOLEMIA WITH HYPOKALEMIC METABOLIC ACIDOSIS
3. DIABETIC KETOACIDOSIS
CONTRAINDICATION:
1. LIVER DISEASE
2. ALONG WITH BLOOD TRANSFUSION (CALCIUM BINDS CITRATE)
3. SEVERE CHF
4. DRUGS (DOXYCYCLINE, AMPICILLINE)
ISOTONIC SALINE
(0.9% NACL)
• INDICATIONS:
1. HYPOVOLEMIC SHOCK
2. ALKALOSIS WITH DEHYDRATION (VOMITING)
3. INITIAL THERAPY IN DKA
CONTRAINDICATIONS:
1. AVOID IN HTN, RENAL DISEASE.
2. DEHYDRATION WITH SEVERE HYPOKALEMIA
DEXTROSE SALINE(DNS)
• 5% DEXTROSE WITH 0.9% NaCl
• INDICATIONS:
1. CORRECTION OF SALT DEPLETION, HYPOVOLEMIA WITH ENERGY SUPPLY
2. COMPATIBLE WITH BLOOD TRANSFUSION.
CONTRAINDICATIONS:
1. SEVERE HYPOVOLEMIC SHOCK
2. ANASARCA OF CARDIAC, HEPATIC, RENAL DISEASE
MONITORING FLUID THERAPY
• Skin, tongue
• Weight
• Sensorium
• Urine output
• Pulse
• Blood pressure
• CVP
• In patient with hypovolemic shock with ongoing hemorrhage, volume
replacement with PRBC is recommended.
• In case of massive transfusion, Platelets and FFP should be provided.
• Most commonly used parameter to assess adequacy of volume
resuscitation are IVC DIAMETER, IVC COLLAPSE.
VASOPRESSOR AND INOTROPIC
SUPPORT
• In patient with distributive shock, norepinephrine is
the first choice vasopressor.
• Vasopressin is safe and used as second agent for
hypotension in septic shock.
• Dobutamine is first line agent in cardiogenic shock.
• CASE SCENARIO
• An 82-year-old man is admitted after being involved in a motor
vehicle collision. He has severe chest and abdominal injuries.
His head and extremities are only minimally traumatized. He
undergoes surgery for a splenic rupture. After eight hours, he
becomes hypotensive and febrile, and is intubated because of
respiratory failure. He rapidly develops disseminated
intravascular coagulation (DIC). Which of the following is the
most likely diagnosis?
• CASE SCENARIO
• A 81 year male, comes to the emergency department looking weak,
lethargic, he’s able to state he is under chemotherapy for
a pancreatic tumor and he has had nausea, vomiting, watery
diarrhea for the last 2 days.
• On inspection: Poor skin turgor, dry mucous membranes.
• His vital signs are: HR 130 beats/minute and regular, BP 62/30 mm
Hg,, RR26 breaths/minute, Temp: 37° C.
THANK YOU

More Related Content

What's hot

ECG: Ventricular Premature Beats
ECG: Ventricular Premature BeatsECG: Ventricular Premature Beats
ECG: Ventricular Premature Beats
Stanley Medical College, Department of Medicine
 
ECG- ST segment
ECG- ST segmentECG- ST segment
ECG Changes in Myocardial Infarction
ECG Changes in Myocardial InfarctionECG Changes in Myocardial Infarction
ECG Changes in Myocardial Infarction
Adeboye Oluwajuyitan
 
Defibrillation
DefibrillationDefibrillation
Defibrillation
Joyce Wilson
 
Defibrillation & Cardioversion
Defibrillation & CardioversionDefibrillation & Cardioversion
Defibrillation & Cardioversion
HIRANGER
 
Arrhythmias 2
Arrhythmias 2Arrhythmias 2
Arrhythmias 2
mona Al-sayed
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
Apollo Hospitals
 
Defibrillation & cardioversion by DJ
Defibrillation & cardioversion by DJDefibrillation & cardioversion by DJ
Defibrillation & cardioversion by DJ
Dharmendra Joshi
 
Management of Cardiogenic shock
Management of Cardiogenic shockManagement of Cardiogenic shock
Management of Cardiogenic shock
Nizam Uddin
 
Arterial line analysis
Arterial line analysisArterial line analysis
Arterial line analysis
samirelansary
 
Cardiac arrythmias
Cardiac arrythmiasCardiac arrythmias
Cardiac arrythmias
Srinivas Sidda
 
Introduction to Shock & Cardiogenic Shock
Introduction to Shock & Cardiogenic ShockIntroduction to Shock & Cardiogenic Shock
Introduction to Shock & Cardiogenic Shock
Arun Vasireddy
 
Cardiogenic shock dr awadhesh
Cardiogenic shock  dr awadheshCardiogenic shock  dr awadhesh
Cardiogenic shock dr awadhesh
LPS Institute of Cardiology Kanpur UP India
 
Defibrillation, cardioversion and pacing
Defibrillation, cardioversion and pacingDefibrillation, cardioversion and pacing
Defibrillation, cardioversion and pacing
snich
 
Approach to a patient in shock
Approach to a patient in shockApproach to a patient in shock
Approach to a patient in shock
Ankur Kaushik
 
Pathophysiology of shock and its management
Pathophysiology of shock and its managementPathophysiology of shock and its management
Pathophysiology of shock and its management
BipulBorthakur
 
Approach to Shock (for Undergraduates)
Approach to Shock (for Undergraduates)Approach to Shock (for Undergraduates)
Approach to Shock (for Undergraduates)
Abdullah Ansari
 
Hemodynamic monitoring
Hemodynamic monitoringHemodynamic monitoring
Hemodynamic monitoring
Krishna R
 
Ventricular arrhythmias
Ventricular arrhythmias Ventricular arrhythmias
Ventricular arrhythmias
Rawalpindi Medical College
 
Cardiogenic shock
Cardiogenic  shockCardiogenic  shock
Cardiogenic shock
Mohammad Ali
 

What's hot (20)

ECG: Ventricular Premature Beats
ECG: Ventricular Premature BeatsECG: Ventricular Premature Beats
ECG: Ventricular Premature Beats
 
ECG- ST segment
ECG- ST segmentECG- ST segment
ECG- ST segment
 
ECG Changes in Myocardial Infarction
ECG Changes in Myocardial InfarctionECG Changes in Myocardial Infarction
ECG Changes in Myocardial Infarction
 
Defibrillation
DefibrillationDefibrillation
Defibrillation
 
Defibrillation & Cardioversion
Defibrillation & CardioversionDefibrillation & Cardioversion
Defibrillation & Cardioversion
 
Arrhythmias 2
Arrhythmias 2Arrhythmias 2
Arrhythmias 2
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Defibrillation & cardioversion by DJ
Defibrillation & cardioversion by DJDefibrillation & cardioversion by DJ
Defibrillation & cardioversion by DJ
 
Management of Cardiogenic shock
Management of Cardiogenic shockManagement of Cardiogenic shock
Management of Cardiogenic shock
 
Arterial line analysis
Arterial line analysisArterial line analysis
Arterial line analysis
 
Cardiac arrythmias
Cardiac arrythmiasCardiac arrythmias
Cardiac arrythmias
 
Introduction to Shock & Cardiogenic Shock
Introduction to Shock & Cardiogenic ShockIntroduction to Shock & Cardiogenic Shock
Introduction to Shock & Cardiogenic Shock
 
Cardiogenic shock dr awadhesh
Cardiogenic shock  dr awadheshCardiogenic shock  dr awadhesh
Cardiogenic shock dr awadhesh
 
Defibrillation, cardioversion and pacing
Defibrillation, cardioversion and pacingDefibrillation, cardioversion and pacing
Defibrillation, cardioversion and pacing
 
Approach to a patient in shock
Approach to a patient in shockApproach to a patient in shock
Approach to a patient in shock
 
Pathophysiology of shock and its management
Pathophysiology of shock and its managementPathophysiology of shock and its management
Pathophysiology of shock and its management
 
Approach to Shock (for Undergraduates)
Approach to Shock (for Undergraduates)Approach to Shock (for Undergraduates)
Approach to Shock (for Undergraduates)
 
Hemodynamic monitoring
Hemodynamic monitoringHemodynamic monitoring
Hemodynamic monitoring
 
Ventricular arrhythmias
Ventricular arrhythmias Ventricular arrhythmias
Ventricular arrhythmias
 
Cardiogenic shock
Cardiogenic  shockCardiogenic  shock
Cardiogenic shock
 

Similar to APPROACH TO SHOCK [Auto-saved].pptx

Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
DanishMandi
 
Shock and its management final/ dental implant courses
Shock and its management final/ dental implant coursesShock and its management final/ dental implant courses
Shock and its management final/ dental implant courses
Indian dental academy
 
2 shock 1
2 shock 12 shock 1
2 shock 1
Engidaw Ambelu
 
shock-180613074042.docx
shock-180613074042.docxshock-180613074042.docx
shock-180613074042.docx
MohammedAqeel39
 
shock.pptx
shock.pptxshock.pptx
shock.pptx
AbdulHamidIdris1
 
Shock
ShockShock
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
Abhishek943418
 
Shock
ShockShock
SHOCK AND ITS COMPLICATIONS.ppt
SHOCK AND ITS COMPLICATIONS.pptSHOCK AND ITS COMPLICATIONS.ppt
SHOCK AND ITS COMPLICATIONS.ppt
TbndkSamuelTesa
 
SHOCK
SHOCKSHOCK
pediatric Shock management seminar ppt slide
pediatric Shock management seminar ppt slidepediatric Shock management seminar ppt slide
pediatric Shock management seminar ppt slide
jerusalemabated
 
circulatory shock.pptx
circulatory shock.pptxcirculatory shock.pptx
circulatory shock.pptx
thanaram patel
 
Resuscitation of a bleeding patient
Resuscitation of a bleeding patientResuscitation of a bleeding patient
Resuscitation of a bleeding patient
Pradeep Balaji
 
shock
shockshock
Neonatal shock management [Autosaved].pptx
Neonatal shock management [Autosaved].pptxNeonatal shock management [Autosaved].pptx
Neonatal shock management [Autosaved].pptx
Raafat Salama
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
NooriMumash
 
Shock.pdf
Shock.pdfShock.pdf
Shock.pdf
Shock.pdfShock.pdf
Shock
ShockShock
Shock
Upwork
 
Shock
ShockShock

Similar to APPROACH TO SHOCK [Auto-saved].pptx (20)

Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
Shock and its management final/ dental implant courses
Shock and its management final/ dental implant coursesShock and its management final/ dental implant courses
Shock and its management final/ dental implant courses
 
2 shock 1
2 shock 12 shock 1
2 shock 1
 
shock-180613074042.docx
shock-180613074042.docxshock-180613074042.docx
shock-180613074042.docx
 
shock.pptx
shock.pptxshock.pptx
shock.pptx
 
Shock
ShockShock
Shock
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Shock
ShockShock
Shock
 
SHOCK AND ITS COMPLICATIONS.ppt
SHOCK AND ITS COMPLICATIONS.pptSHOCK AND ITS COMPLICATIONS.ppt
SHOCK AND ITS COMPLICATIONS.ppt
 
SHOCK
SHOCKSHOCK
SHOCK
 
pediatric Shock management seminar ppt slide
pediatric Shock management seminar ppt slidepediatric Shock management seminar ppt slide
pediatric Shock management seminar ppt slide
 
circulatory shock.pptx
circulatory shock.pptxcirculatory shock.pptx
circulatory shock.pptx
 
Resuscitation of a bleeding patient
Resuscitation of a bleeding patientResuscitation of a bleeding patient
Resuscitation of a bleeding patient
 
shock
shockshock
shock
 
Neonatal shock management [Autosaved].pptx
Neonatal shock management [Autosaved].pptxNeonatal shock management [Autosaved].pptx
Neonatal shock management [Autosaved].pptx
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
Shock.pdf
Shock.pdfShock.pdf
Shock.pdf
 
Shock.pdf
Shock.pdfShock.pdf
Shock.pdf
 
Shock
ShockShock
Shock
 
Shock
ShockShock
Shock
 

Recently uploaded

“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Université de Montréal
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
MwambaChikonde1
 
All about shoulder Joint ..
All about shoulder Joint .. All about shoulder Joint ..
All about shoulder Joint ..
Aswan University Hospital
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
MuskanShingari
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
MuskanShingari
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Mobile Problem
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and LeukotrienesPharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Dr. Nikhilkumar Sakle
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Call Girls Lucknow 9024918724 Vip Call Girls Lucknow
Call Girls Lucknow 9024918724 Vip Call Girls LucknowCall Girls Lucknow 9024918724 Vip Call Girls Lucknow
Call Girls Lucknow 9024918724 Vip Call Girls Lucknow
nandinirastogi03
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 

Recently uploaded (20)

“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
 
All about shoulder Joint ..
All about shoulder Joint .. All about shoulder Joint ..
All about shoulder Joint ..
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
Gene Expression System-viral gene delivery Mpharm(Pharamaceutics)
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and LeukotrienesPharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Call Girls Lucknow 9024918724 Vip Call Girls Lucknow
Call Girls Lucknow 9024918724 Vip Call Girls LucknowCall Girls Lucknow 9024918724 Vip Call Girls Lucknow
Call Girls Lucknow 9024918724 Vip Call Girls Lucknow
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 

APPROACH TO SHOCK [Auto-saved].pptx

  • 1. APPROACH TO SHOCK MODERATOR: DR JAI GAWLI SIR PRESENTER: DR AYUSHI MUNGAD
  • 2. DEFINITION • Shock is clinical condition of organ dysfunction resulting from imbalance between cellular oxygen supply and demand. • Life threatening condition. • Organ dysfunction in early shock is reversible. • If left untreated, goes in irreversible phase and death occur from multisystem organ dysfunction.
  • 3. PATHOPHYSIOLOGY OF SHOCK • Most commonly related to impaired oxygen delivery in the setting of circulatory failure. • Can also develop during states of increased oxygen consumption or impaired oxygen utilization.
  • 4.
  • 5. • Normal oxygen content in mitochondria is 10 mmHg. • Critical value in mitochondria is 1-2 mmHg, Below this anerobic respiration sets in. • Major oxygen consumers are LIVER, BRAIN, HEART, SKELETAL MUSCLE, KIDNEY, SKIN.
  • 6. INSUFFICIENT OXYGEN SUPPLY ANAEROBIC METABOLISM INADEQUATE ATP SUPPLY OSMOTIC, IONIC DISRUPTION CELLULAR SWELLING CELL DEATH
  • 7. CLASSIFICATION OF SHOCK • Based on the primary physiologic derangement, shock is classified in four major types: 1. DISTRIBUTIVE 2. CARDIOGENIC 3. OBSTRUCTIVE 4. HYPOVOLEMIC
  • 8. PATHOPHYSIOLOGIC CLASSIFICATION OF SHOCK 1. DISTRIBUTIVE SHOCK • SEPTIC SHOCK • ANAPHYLACTIC SHOCK • NEUROGENIC SHOCK 2. CARDIOGENIC SHOCK • MYOCARDIAL INFARCTION • VALVULAR INSUFFICIENCY 3. OBSTRUCTIVE SHOCK • TENSION PNEUMOTHORAX • INTRATHORACIC TUMOR • PULMONARY EMBOLISM 4. HYPOVOLEMIC SHOCK • BURNS • GI LOSSES • HEMORRHAGE • DIABETIC KETOACIDOSIS • DIABETIC INSIPIDUS
  • 9. DISTRIBUTIVE SHOCK • It is the condition of reduced systemic vascular resistance. • It is unique among the types of shock because there is compensatory increase in cardiac output. • Most common cause of distributive shock is sepsis.
  • 10. • Sepsis: A life threatening organ dysfunction caused by dysregulated host response to infection. • Septic shock: Suspected infection (or documented) plus vasopressor therapy to maintain MAP >65mmHg and serum lactate >2mmol/L despite adequate fluid resuscitation.
  • 11. SYSTEMIC INFLAMMATORY RESPONSE SYNDROME SEPSIS SEPTIC SHOCK MULTI ORGAN DYSFUNCTION SYNDROME
  • 12.
  • 13.
  • 14. • ANAPHYLACTIC SHOCK: Predominantly IgE mediated allergic reaction rapidly develop after exposure to an ALLERGEN. • It is mediated through histamine release. • Both arterial and venous vasodilation occur.
  • 15. NEUROGENIC SHOCK • In high spinal injuries there is failure of sympathetic outflow. • Vasodilation • Pooling of blood • Decrease venous return • Decrease cardiac output • It is sudden in onset.
  • 16. HYPOVOLEMIC SHOCK • It is due to reduce cardiac output(and oxygen delivery) via a reduction in preload. • Most commonly related to hemorrhage, may be external or internal. • Non-hemorrhagic processes(GI, Renal, Skin loss) can also lead to hypovolemic shock.
  • 17. CLASSIFICATION OF HYPOVOLEMIC SHOCK I II III IV % OF VOLUME LOSS 0-15% 15-30% 30-40% >40% AMOUNT OF BLOOD LOSS 400-500mL 500-1500mL 1500-2000mL >2000mL HR NORMAL NR SBP NORMAL NORMAL NR DBP NORMAL NR RR NORMAL NORMAL UO NORMAL NORMAL/ ANURIA
  • 18. I II III IV MENTAL STATUS NORMAL ANXIOUS AND THIRSTY CONFUSED COMA MANGEMENT ORAL LIQUIDS IV CRYSTALLOIDS IV CRYSTALLOIDS + COLLOIDS MASSIVE BLOOD TRANFUSION
  • 19. CARDIOGENIC SHOCK • It is characterized by reduced oxygen delivery related to reduction in cardiac output owing to a primary cardiac problem. • When affects LV, PCWP will be elevated. • When affects RV, CVP will be elevated.
  • 20. OBSTRUCTIVE SHOCK • Reduction in oxygen delivery is related to reduced CO due to an extracardiac process impairing blood flow. • Some process can impede venous return and other obstruct cardiac flow.
  • 21. • MIXED SHOCK: Patient will present with more than one type of shock. • UNDIFFERENTIATED SHOCK
  • 22. HEMODYNAMIC CHARACTERISTIC OF MAJOR TYPES OF SHOCK TYPE OF SHOCK CVP PCWP CARDIAC OUTPUT SYSTEMIC VASCULAR RESISTANCE DISTRIBUTIVE DECREASE DECREASE INCREASE DECREASE CARDIOGENIC INCREASE INCREASE DECREASE INCREASE OBSTRUCTIVE INCREASE INCREASE OR DECREASE DECREASE INCREASE HYPOVOLEMIC DECREASE DECREASE DECREASE INCREASE
  • 24. EVALUATION OF PATIENT WITH SHOCK
  • 25. KEY PRINCIPLES IN THE TREATMENT OF SHOCK 1. RECOGNIZE SHOCK EARLY.. 2.ASSESS FOR THE TYPE OF SHOCK PRESENT 3. INITIATE THERAPY SIMULTANEOUS WITH THE EVALUATION INTO ETIOLOGY OF SHOCK. 4. RESTORATION OF OXYGEN DELIVERY IS THE AIM OF THERAPY. 5. IDENTIFY ETIOLOGIES WHICH REQUIRE ADDITIONAL LIFE SAVING INTERVENTIONS
  • 26. HISTORY TAKING • In some cases, the type of shock is apparent from history. • The most easily identified new organ dysfunction is presence of altered mental status or decrease renal function.
  • 27. • DISTRIBUTIVE SHOCK FROM SEPSIS- FEVER, FOCAL SITE OF INFECTION. • DISTRIBUTIVE SHOCK FROM ANAPHYLAXIS- DYSPNEA, NEW FACIAL EDEMA, PRURITIS AFTER EXPOSURE TO ALLERGEN. • CARDIOGENIC SHOCK: EXERTIONAL CHEST DISCOMFORT, PALPITATION, CHEST PAIN.
  • 28. • HYPOVOLEMIC SHOCK: History of trauma or GI bleed. • OBSTRUCTIVE SHOCK: Tearing chest or back pain with history of HTN or acute onset chest pain with dyspnea in the setting of immobility.
  • 29. PHYSICAL EXAMINATION Physical examination should be conducted with aim of answering 2 questions: 1.IS SHOCK PRESENT? 2. WHAT TYPE OF SHOCK PRESENT?
  • 30. • DURING COMPENSATED PHASE: TACHYCARDIA, TACHYPNEA. • HYPOTENSION MAY ALSO BE PRESENT. • CNS, KIDNEY AND SKIN ARE THE ORGAN MOST EASILY ASSESED FOR EVIDENCE OF DYSFUNCTION.
  • 31. • WARM EXTREMITIES: DISTRIBUTIVE SHOCK. • COLD EXTREMITIES: HYPOVOLEMIC SHOCK, OBSTRUCTIVE SHOCK, CARDIOGENIC SHOCK. • URINARY OUTPUT SHOULD BE ASSESED.
  • 32. • JVP AND PERIPHERAL EDEMA can provide insight into right side cardiac pressure. • PULMONARY AUSCULTATION can identify signs of left sided cardiac dysfunction. • Examination may demonstrate site of untreated infection, large ecchymosis.
  • 33. SCORING SYSTEM • SHOCK INDEX (SI)= HR/ SYSTOLIC BLOOD PRESSURE • NORMAL SI IS 0.5-0.7. • SI >0.9 IS MORE SENSITIVE INDICATOR OF TRANSFUSION REQUIREMENT.
  • 34. QSOFA • IT IS A RAPID ASSESSMENT SCALE THAT ASSIGNS A POINT FOR 1. SBP <1OO mmHg. 2. RR >22/MIN. 3. ALTERED MENTAL STATUS. • qSOFA OF >2 IS ASSOCIATED WITH SIGNIFICANTLY GREATER RISK OF PROLONGED ICU STAY OR DEATH.
  • 35. INITIAL LABORATORY EVALUATION OF UNDIFFERENTIATED SHOCK 1. LACTATE 2. RENAL FUNCTION TEST 3. LIVER FUNCTION TEST 4. CARDIAC ENZYMES 5. COMPLETE BLOOD COUNT 6. PT, INR 7. URINALYSIS 8. ABG 9. ECG
  • 36. INITIAL TREATMENT OF SHOCK • VOLUME RESUSCITATION • VASOPRESSOR AND INOTROPIC SUPPORT • OXYGEN AND VENTILLATION SUPPORT • ANTIBIOTIC SUPPORT
  • 37. VOLUME RESUSCITATION • Aim is to restore tissue perfusion . • Patient with suspected septic shock, minimum 30ml/kg is recommended by surviving sepsis campaign in 1 hr. • Most commonly volume resuscitation begin with crystalloid.
  • 38. RINGER LACTATE INDICATIONS: 1. SEVERE HYPOVOLEMIA 2. DIARRHOEA INDUCED HYPOVOLEMIA WITH HYPOKALEMIC METABOLIC ACIDOSIS 3. DIABETIC KETOACIDOSIS CONTRAINDICATION: 1. LIVER DISEASE 2. ALONG WITH BLOOD TRANSFUSION (CALCIUM BINDS CITRATE) 3. SEVERE CHF 4. DRUGS (DOXYCYCLINE, AMPICILLINE)
  • 39. ISOTONIC SALINE (0.9% NACL) • INDICATIONS: 1. HYPOVOLEMIC SHOCK 2. ALKALOSIS WITH DEHYDRATION (VOMITING) 3. INITIAL THERAPY IN DKA CONTRAINDICATIONS: 1. AVOID IN HTN, RENAL DISEASE. 2. DEHYDRATION WITH SEVERE HYPOKALEMIA
  • 40. DEXTROSE SALINE(DNS) • 5% DEXTROSE WITH 0.9% NaCl • INDICATIONS: 1. CORRECTION OF SALT DEPLETION, HYPOVOLEMIA WITH ENERGY SUPPLY 2. COMPATIBLE WITH BLOOD TRANSFUSION. CONTRAINDICATIONS: 1. SEVERE HYPOVOLEMIC SHOCK 2. ANASARCA OF CARDIAC, HEPATIC, RENAL DISEASE
  • 41. MONITORING FLUID THERAPY • Skin, tongue • Weight • Sensorium • Urine output • Pulse • Blood pressure • CVP
  • 42. • In patient with hypovolemic shock with ongoing hemorrhage, volume replacement with PRBC is recommended. • In case of massive transfusion, Platelets and FFP should be provided. • Most commonly used parameter to assess adequacy of volume resuscitation are IVC DIAMETER, IVC COLLAPSE.
  • 43. VASOPRESSOR AND INOTROPIC SUPPORT • In patient with distributive shock, norepinephrine is the first choice vasopressor. • Vasopressin is safe and used as second agent for hypotension in septic shock. • Dobutamine is first line agent in cardiogenic shock.
  • 44. • CASE SCENARIO • An 82-year-old man is admitted after being involved in a motor vehicle collision. He has severe chest and abdominal injuries. His head and extremities are only minimally traumatized. He undergoes surgery for a splenic rupture. After eight hours, he becomes hypotensive and febrile, and is intubated because of respiratory failure. He rapidly develops disseminated intravascular coagulation (DIC). Which of the following is the most likely diagnosis?
  • 45. • CASE SCENARIO • A 81 year male, comes to the emergency department looking weak, lethargic, he’s able to state he is under chemotherapy for a pancreatic tumor and he has had nausea, vomiting, watery diarrhea for the last 2 days. • On inspection: Poor skin turgor, dry mucous membranes. • His vital signs are: HR 130 beats/minute and regular, BP 62/30 mm Hg,, RR26 breaths/minute, Temp: 37° C.

Editor's Notes

  1. NORMAL ENDOTHELIUM SHEILDS COAGULATION FACTORS FROM TISSUE FACTORS IN VESSEL WALL AND EXPRESSES MULTIPLE FACTORS THAT OPPOSES COAGULATION
  2. norepi 5-30 mcg/min 0.01- 3.30 /kg/min vasopr 0.01-0.04 u/min dobutamine- 2-20